Global Neonatal Genetic Disease Diagnosis Market Growth (Status and Outlook) 2024-2030

Global Neonatal Genetic Disease Diagnosis Market Growth (Status and Outlook) 2024-2030

Neonatal genetic disease diagnosis refers to the process of identifying genetic disorders in newborns, typically through a combination of genetic testing, clinical evaluation, and family history analysis. This diagnostic process is crucial for early detection and management of genetic conditions, which can significantly impact a child's health and development.

The global Neonatal Genetic Disease Diagnosis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Neonatal Genetic Disease Diagnosis Industry Forecast” looks at past sales and reviews total world Neonatal Genetic Disease Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Neonatal Genetic Disease Diagnosis sales for 2023 through 2029. With Neonatal Genetic Disease Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neonatal Genetic Disease Diagnosis industry.

This Insight Report provides a comprehensive analysis of the global Neonatal Genetic Disease Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neonatal Genetic Disease Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neonatal Genetic Disease Diagnosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neonatal Genetic Disease Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neonatal Genetic Disease Diagnosis.

United States market for Neonatal Genetic Disease Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Neonatal Genetic Disease Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Neonatal Genetic Disease Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Neonatal Genetic Disease Diagnosis players cover Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Neonatal Genetic Disease Diagnosis market by product type, application, key players and key regions and countries.

Segmentation by Type:
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others

Segmentation by Application:
Hospital
Medical Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others

Segmentation by Application:
Hospital
Medical Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology

Please note: The report will take approximately 2 business days to prepare and deliver.